Masuda Shigeo, Ageyama Naohide, Shibata Hiroaki, Obara Yoko, Ikeda Tamako, Takeuchi Kengo, Ueda Yasuji, Ozawa Keiya, Hanazono Yutaka
Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
Exp Hematol. 2009 Oct;37(10):1250-1257.e1. doi: 10.1016/j.exphem.2009.07.008. Epub 2009 Jul 26.
Hematopoietic stem cells (HSCs) reside in the osteoblastic niche, which consists of osteoblasts. Mesenchymal stromal cells (MSCs) have an ability to differentiate into osteoblasts. Here, using nonhuman primates, we investigated the effects of cotransplantation with MSCs on the engraftment of HSCs after autologous intra-bone marrow transplantation.
From three cynomolgus monkeys, CD34-positive cells (as HSCs) and MSCs were obtained. The former were divided into two equal aliquots and each aliquot was genetically marked with a distinctive retroviral vector to track the in vivo fate. Each HSC aliquot with or without MSCs was autologously injected into the bone marrow (BM) cavity of right or left side, enabling the comparison of in vivo fates of the two HSC grafts in the same body.
In the three monkeys, CD34(+) cells transplanted with MSCs engrafted 4.4, 6.0, and 1.6 times more efficiently than CD34(+) cells alone, as assessed by BM colony polymerase chain reaction. In addition, virtually all marked cells detected in the peripheral blood were derived from the cotransplantation aliquots. Notably, colony-forming units derived from the cotransplantation aliquots were frequently detected in BM distant sites from the injection site, implying that cotransplantation with MSCs also restored the ability of gene-marked HSCs to migrate and achieve homing in the distant BM.
Cotransplantation with MSCs would improve the efficacy of transplantation of gene-modified HSCs in primates, with enhanced engraftment in BM as well as increased chimerism in peripheral blood through migration and homing.
造血干细胞(HSCs)存在于由成骨细胞组成的成骨细胞龛中。间充质基质细胞(MSCs)具有分化为成骨细胞的能力。在此,我们使用非人类灵长类动物,研究了与MSCs共移植对自体骨髓内移植后HSCs植入的影响。
从三只食蟹猴中获取CD34阳性细胞(作为HSCs)和MSCs。前者被分成两个相等的等分试样,每个等分试样用独特的逆转录病毒载体进行基因标记,以追踪其体内命运。将每个含有或不含有MSCs的HSC等分试样自体注射到右侧或左侧骨髓(BM)腔中,以便比较同一体内两种HSC移植物的体内命运。
通过骨髓集落聚合酶链反应评估,在这三只猴子中,与MSCs共移植的CD34(+)细胞的植入效率分别比单独的CD34(+)细胞高4.4倍、6.0倍和1.6倍。此外,在外周血中检测到的几乎所有标记细胞均来自共移植等分试样。值得注意的是,在远离注射部位的骨髓中经常检测到源自共移植等分试样的集落形成单位,这意味着与MSCs共移植还恢复了基因标记的HSCs迁移并在远处骨髓中归巢的能力。
与MSCs共移植可提高灵长类动物中基因修饰的HSCs的移植效果,增强骨髓植入,并通过迁移和归巢增加外周血中的嵌合现象。